Oslo, Norway 8 May 2019 - The shareholders of PCI Biotech Holding ASA are
invited to attend the Annual General Meeting 2019 at Oslo Cancer Cluster
Innovation Park.
Time: Wednesday May 29, 10am CEST (local time).
Venue: Jónas Einarsson Auditorium (2nd floor, entrance 2B), Oslo Cancer Cluster
Innovation Park, Ullernchausséen 64, Oslo, Norway.
The notice including attendance, proxy and advance voting forms will be mailed
to all shareholders with known address. The complete notice, including executive
remuneration statement and the recommendation from the Nomination Committee, is
attached to this notification and will also be available at PCI Biotech's
corporate website www.pcibiotech.com (http://www.pcibiotech.com).
For further information, please contact:
Ronny Skuggedal, CFO, E-mail: rs@pcibiotech.no
Office: +47 67 11 54 00 Mobile: +47 94 00 57 57
This information is subject to the disclosure requirements pursuant to section
5 -12 of the Norwegian Securities Trading Act.